We welcome you to attend the 31st International Conference on Cancer Research and therapy from September 09-10, 2019 at Zurich, Switzerland which melds brief Keynote presentations, speaker talks, Exhibition, Symposia, workshops and special sessions. This event is CME and CPD Accredited.
The event is in collaboration with the Egyptian Society of Oncology, Pink Ribbon , MAHAK- Society for children suffering from Cancer ,Placid Way, Infomed, Med gadget, Verdict Hospitals and many more.
Organizing Committee Members for the event are:
• Qiao Li – Professor, University of Michigan, USA
• Alireza Heidari Professor California South University, USA
• Jan Jacques Michiels, Professor, Goodheart Institute, Netherlands
• Abdulqader Al-Hebshi, Professor, National Guard Health Affairs, Saudi Arabia
• Raed Haleem, Professor, University of Kufa Najaf, Iraq
Cancer Research 2019 Emphasizes on:
Cancer Research | Cancer Genetics | Cancer Epigenetics | Cancer Science | Cancer diagnostics| Cancer Therapies & prevention| Cancer Stem Cells| Biomarkers| Biopsy| Chemotherapy| Cancer screening | Cancer Immunotherapy many more topics
Gaps, incorrect or incomplete implementation of safety functionality can delay or make the certification/approval of medical products impossible. Most activities cannot be retroactively performed since they are closely linked into the development lifecycle. Diligent, complete and correct implementation of risk management from the start of product development is therefore imperative. This course will introduce all necessary steps to design, implement and test critical medical devices in a regulatory compliant environment. This course will additionally address the software risk management and the resulting interfaces to device level risk management.
To comprehensively summarize all risk related activities and to demonstrate the safe properties of a device the ‘Safety Case’ or ‘Assurance Case’ document is a well-established method to collect all safety related information together in one place. This documentation will most likely become mandatory for all devices (currently only required for FDA infusion pump submissions). This course will introduce the basic concepts and content of safety assurance cases and will illustrate the usefulness for internal and external review of safety related information.
Who Will Benefit:
The course will introduce the main elements of risk management with emphasis on the application of risk management principles and requirements to the medical device development cycle. Risk management has become the method of choice to ensure an effective and safety oriented device development. International consensus, reflected in globally applicable standard requirements, has led to risk management being a mandatory component of almost any activity in the medical device industry.
• Quality professionals
• Regulatory professionals
• Compliance professionals
• Project managers
• Design engineers
• Software engineers
• Process owners
• Quality engineers
• Quality auditors
• Medical affairs
• Legal Professionals